Keros Therapeutics (KROS) Net Income Growth (3y) (2022 - 2025)
Keros Therapeutics (KROS) Net Income Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Keros Therapeutics | 383.01 Mn | 95.61 Mn | - | 7.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.58% |
| Sep 30, 2025 | 32.35% |
| Jun 30, 2025 | -4.03% |
| Mar 31, 2025 | 101.14% |
| Dec 31, 2024 | -87.88% |
| Sep 30, 2024 | -37.67% |
| Jun 30, 2024 | -42.56% |
| Mar 31, 2024 | -39.49% |
| Dec 31, 2023 | -62.22% |
| Sep 30, 2023 | -85.54% |
| Jun 30, 2023 | -104.08% |
| Mar 31, 2023 | -49.04% |
| Dec 31, 2022 | -121.06% |
| Sep 30, 2022 | -87.81% |
| Jun 30, 2022 | -112.21% |
| Mar 31, 2022 | -96.60% |